Abnormal metabolic pattern associated with cognitive impairment in Parkinson's disease: a validation study
Sanne K Meles1, Chris C Tang2, Laura K Teune1
1Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Summary
The Parkinson
Area of Science:
- Neuroscience
- Medical Imaging
- Metabolic Research
Background:
- Cognitive deficits are common in Parkinson's disease (PD).
- A specific metabolic covariance pattern, the PD cognition-related pattern (PDCP), has been linked to cognitive performance in PD.
- Reproducibility of the PDCP topography across different PD populations remains unconfirmed.
Purpose of the Study:
- To determine if the PDCP topography is reproducible in a new cohort of Dutch Parkinson's disease patients.
- To validate the PDCP as a reliable imaging marker for cognitive dysfunction in PD.
Main Methods:
- Network analysis of metabolic scans from 19 Dutch PD subjects.
- Correlation analysis between PDCP expression and executive function (Frontal Assessment Battery - FAB).
- Validation in an independent cohort of 86 American PD patients.
Main Results:
- A significant PDCP was identified in the Dutch cohort, closely resembling the original topography.
- PDCP expression correlated significantly with executive dysfunction (FAB scores).
- PDCP scores showed high correlation between original and new topographies, and with cognitive performance in both Dutch and American cohorts.
Conclusions:
- The PDCP topography is reproducible across independent Parkinson's disease populations.
- The PDCP serves as a replicable neuroimaging marker for cognitive dysfunction in Parkinson's disease.
- This finding supports the use of PDCP in understanding and potentially diagnosing cognitive impairments in PD.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Neural Regulation
45.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Inborn Errors of Metabolism
1.0K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Overview of Protein Metabolism
4.8K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.8K


